NNUP · Nocopi Technologies Inc/Md/

On December 29, 2025, the Reporting Person was granted restricted stock units, of which 5,000 vested immediately on the grant date and the remaining 5,000 will vest on December 29, 2026. Each restricted stock unit represents a contingent right to receive one share of Nocopi Technologies, Inc. (the "Company") common stock.

On December 29, 2025, the Reporting Person was granted restricted stock units, of which 5,000 vested immediately on the grant date and the remaining 5,000 will vest on December 29, 2026. Each restricted stock unit represents a contingent right to receive one share of Nocopi Technologies, Inc. (the "Company") common stock.

On December 29, 2025, the Company withheld 2,360 shares of common stock in satisfaction of the Reporting Person's tax obligations in connection with the above mentioned vesting of outstanding restricted stock units.

On December 31, 2025, the Reporting Person entered into a Stock Purchase Agreement between the Company and the Reporting Person whereby the Reporting Person agreed to purchase 33,333 shares of the Company's common stock at a price of $1.50 per share in a private placement.

On December 29, 2025, the Reporting Person was granted restricted stock units, of which 10,000 vested immediately on the grant date and the remaining 10,000 will vest on December 29, 2026. Each restricted stock unit represents a contingent right to receive one share of Nocopi Technologies, Inc. (the "Company") common stock.

On December 23, 2024, the Reporting Person was granted restricted stock units, of which 5,000 vested immediately on the grant date and the remaining 5,000 vested on December 24, 2025. Each restricted stock unit represents a contingent right to receive one share of Nocopi Technologies, Inc. (the "Company") common stock.

On December 23, 2024, the Reporting Person was granted restricted stock units, of which 5,000 vested immediately on the grant date and the remaining 5,000 vested on December 24, 2025. Each restricted stock unit represents a contingent right to receive one share of Nocopi Technologies, Inc. (the "Company") common stock.

On December 24, 2025, 5,000 shares underlying the previously granted restricted stock units vested.

On December 24, 2025, the Company withheld 2,360 shares of common stock in satisfaction of the Reporting Person's tax obligations in connection with the above mentioned vesting of outstanding restricted stock units.

Represents shares of the Issuer's common stock acquired by the Reporting Person from the Issuer as consideration rendered pursuant advisory services provided by the Reporting Person pursuant to that certain Stock Purchase Agreement by and between the Issuer and Frost Gamma Investments Trust, dated September 11, 2023.

These securities are held by Frost Gamma Investments Trust, of which the Reporting Person is the trustee. Frost Gamma Limited Partnership is the sole and exclusive beneficiary of Frost Gamma Investments Trust. The Reporting Person is one of two limited partners of Frost Gamma Limited Partnership. The general partner of Frost Gamma Limited Partnership is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation, of which the Reporting Person is the sole shareholder. The Reporting Person disclaims beneficial ownership of the securities held by Frost Gamma Investments Trust except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $1.60 to $1.64, inclusive. The reporting person undertakes to provide Nocopi Technologies, Inc. ("Nocopi"), any security holder of Nocopi, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $1.55 to $1.60, inclusive. The reporting person undertakes to provide Nocopi Technologies, Inc. ("Nocopi"), any security holder of Nocopi, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

These securities were acquired by the Reporting Person from a non-affiliate shareholder of Nocopi Technologies, Inc. in a private secondary transaction exempt from the registration requirements of the Securities Act of 1933, as amended.

These securities were acquired by the Reporting Person from a non-affiliate shareholder of Nocopi Technologies, Inc. in a private secondary transaction exempt from the registration requirements of the Securities Act of 1933, as amended.

These securities were acquired by the Reporting Person from a non-affiliate shareholder of Nocopi Technologies, Inc. in a private secondary transaction exempt from the registration requirements of the Securities Act of 1933, as amended.

These securities are held by Frost Gamma Investments Trust, of which the Reporting Person is the trustee. Frost Gamma Limited Partnership is the sole and exclusive beneficiary of Frost Gamma Investments Trust. The Reporting Person is one of two limited partners of Frost Gamma Limited Partnership. The general partner of Frost Gamma Limited Partnership is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation, of which the Reporting Person is the sole shareholder. The Reporting Person disclaims beneficial ownership of the securities held by Frost Gamma Investments Trust except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

On December 24, 2024, the Reporting Person was granted restricted stock units, of which 5,000 vested immediately on the grant date and the remaining 5,000 shall vest on December 24, 2025. Each restricted stock unit represents a contingent right to receive one share of Nocopi Technologies, Inc. (the "Company") common stock.

On December 24, 2024, 5,000 shares underlying the previously granted restricted stock units vested.

On December 24, 2024, the Reporting Person was granted restricted stock units, of which 5,000 vested immediately on the grant date and the remaining 5,000 shall vest on December 24, 2025. Each restricted stock unit represents a contingent right to receive one share of Nocopi Technologies, Inc. (the "Company") common stock.

This Form 4/A is being filed to correct a typographical error in the Derivative Securities Owned Following the Reported Transaction from 10,000 to 5,000 and to correct the grant date to December 24, 2024.

On December 24, 2024, the Reporting Person was granted restricted stock units, of which 5,000 vested immediately on the grant date and the remaining 5,000 shall vest on December 24, 2025. Each restricted stock unit represents a contingent right to receive one share of Nocopi Technologies, Inc. (the "Company") common stock.

This Form 4/A is being filed to correct a typographical error in the Derivative Securities Owned Following the Reported Transaction from 10,000 to 5,000 and to correct the grant date to December 24, 2024.

On December 23, 2024, the Reporting Person forfeited restricted stock units previously granted to the Reporting Person on August 16, 2024.

This Form 4/A is being filed to correct a typographical error in the Common Stock amount reported acquired from 6,000 to 60,000.

On August 16, 2024, the Reporting Person was granted restricted stock units, which vest ratably quarterly over a two-year period beginning on August 16, 2024. Each restricted stock unit represents a contingent right to receive one share of Nocopi Technologies, Inc. (the "Company") common stock.

On November 16, 2024, 206,221 shares underlying the previously granted restricted stock units vested. In connection with such vesting, the Company withheld 61,416 shares of common stock to cover the Reporting Person's tax obligation in connection with the vesting event.

On August 16, 2024, the Reporting Person was granted restricted stock units, which vest ratably quarterly over a two-year period beginning on August 16, 2024. Each restricted stock unit represents a contingent right to receive one share of Nocopi Technologies, Inc. (the "Company") common stock.

On November 16, 2024, 206,221 shares underlying the previously granted restricted stock units vested. In connection with such vesting, the Company withheld 61,416 shares of common stock to cover the Reporting Person's tax obligation in connection with the vesting event.

Represents shares of the Issuer's common stock acquired by the Reporting Person from the Issuer as consideration rendered pursuant advisory services provided by the Reporting Person pursuant to that certain Stock Purchase Agreement by and between the Issuer and Frost Gamma Investments Trust, dated September 11, 2023.

These securities are held by Frost Gamma Investments Trust, of which the Reporting Person is the trustee. Frost Gamma Limited Partnership is the sole and exclusive beneficiary of Frost Gamma Investments Trust. The Reporting Person is one of two limited partners of Frost Gamma Limited Partnership. The general partner of Frost Gamma Limited Partnership is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation, of which the Reporting Person is the sole shareholder. The Reporting Person disclaims beneficial ownership of the securities held by Frost Gamma Investments Trust except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Each restricted stock unit represents a contingent right to receive one share of Nocopi Technologies, Inc. (the "Company") common stock.

On August 16, 2024, the Reporting Person agreed to cancel a prior grant (the "Prior Grant") to the Reporting Person of 1,000,000 restricted stock units of the Company granted to the Reporting Person by the Company's Board of Directors (the "Board") on October 10, 2023. The grant disclosed in Table II was granted to the Reporting Person by the Board on August 16, 2024 as a replacement in lieu of the Prior Grant.

The restricted stock units vest ratably quarterly over a two-year period beginning on August 16, 2024.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.94 to $2.99, inclusive. The reporting person undertakes to provide to Nocopi Technologies, Inc. ("Nocopi"), any security holder of Nocopi, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.78 to $2.99, inclusive. The reporting person undertakes to provide to Nocopi Technologies, Inc. ("Nocopi"), any security holder of Nocopi, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This amount has been adjusted to reflect the one-for-ten reverse stock split effected by Nocopi Technologies, Inc. ("Nocopi") on September 2, 2022, as reported by Nocopi in its Form 8-K filed with the Securities and Exchange Commission on August 25, 2022.

This amount has been adjusted to reflect the one-for-ten reverse stock split effected by Nocopi Technologies, Inc. ("Nocopi") on September 2, 2022, as reported by Nocopi in its Form 8-K filed with the Securities and Exchange Commission on August 25, 2022.

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.16 to $0.17, inclusive. The reporting person undertakes to provide to Nocopi, any security holder of Nocopi, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.15 to $0.17, inclusive. The reporting person undertakes to provide to Nocopi, any security holder of Nocopi, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.